Advances in Early Alzheimer’s Detection

Advances in Early Alzheimer’s Detection

The prevalence of Alzheimer’s disease (AD) is rapidly increasing as individual life spans across the world increase.  It is currently the most common form of dementia, marked by the overproduction and aggregation of amyloid β (Aβ) and tau proteins in the brain. These...

read more
The Promise of Biosimilar Drugs

The Promise of Biosimilar Drugs

In 2006, the European Medicines Agency granted its first approval of a biosimilar drug, the human growth hormone, Omnitrope™ (Sandoz), and opened the doors of opportunity for this emerging field of medicine. In 2010, President Obama signed into law the Biosimilars...

read more